Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China

Fig. 2

Subgroup Kaplan-Meier analysis of DFS (A) and OS (B) for patients with different CNLC stages who received adjuvant TACE or not; Subgroup forest plots of DFS (C) and OS (D) at 1, 2, and 3 years for patients with different risk factors who received adjuvant TACE or not. DFS, Disease-free survival; OS, Overall survival; CNLC, Chinese liver cancer; TACE, Transarterial chemoembolization; AFP, Alpha-fetoprotein; LMR, Lymphocyte-to-monocyte ratio; MVI, Microvascular invasion; CNLC, Chinese liver cancer

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us